In its August 16, 2016 issue of The Journal of the American Medical Association (JAMA), the phase 3 results of the Abaloparatide Comparator Trial In Vertebral Endpoints (ACTIVE) trial were released. Read this article here! An accompanying editorial can be found here.
On July 14, 2016, the Centers for Medicare and Medicaid Services (CMS) published the proposed rule for the Hospital Outpatient Prospective Payment System (HOPPS) for 2017. CMS has proposed to cut the reimbursement rate for Axial DXA, CPT 77080 in the hospital setting from the current national average of $100.69 to $63.33. This reimbursement cut will… Read more »
Millions of Americans are missing out on a chance to avoid debilitating fractures from weakened bones, researchers say, because they are terrified of exceedingly rare side effects from drugs that can help them. Last month, the American Society for Bone and Mineral Research, the National Osteoporosis Foundation and the National Bone Health Alliance put out… Read more »
One our Corporate Advisory Roundtable members, Juvent, announced very positive results from the St. Jude Children’s Hospital Clinical Trial. An 11% increase in bone density was seen in childhood cancer survivors through their product, Juvent® Dynamic Motion Therapy Platform. The study was published in the Journal of the American Medical Association (JAMA) Oncology. To learn more,… Read more »
NOF is pleased to share interviews recorded by the Medicare Nation podcast, media partner for NOF’s annual conference, the Interdisciplinary Symposium on Osteoporosis, held May 12-15, 2016 in Miami, FL. Medicare Nation is a weekly podcast dedicated to bringing listeners everything they need to know about Medicare but are afraid to ask. They feature interviews… Read more »
The Nation’s leading scientific and medical bone health experts call for action on the dangers of not treating osteoporosis more aggressively. They are urging healthcare professionals to increase diagnosis and patients to be aware of this risk. Read statements released by leading organizations in the field in this PRNewswire article.
The results of this large scale genomic study provide insights into the genetics underlying osteoporosis and may lead to new ways to prevent bone loss and fractures. Read more about the bone risks linked to genetic variants.
An Editorial Published in Osteoporosis International Responds to the BMJ Article Claiming an Overdiagnosis of Osteoporosis An editorial published this week in Osteoporosis International responds to the recent British Medical Journal (BMJ) article that claimed osteoporosis is overdiagnosed. The editorial, authored by Professor Juliet Compston, Chair of the National Osteoporosis Guideline Group and IOF EU… Read more »
Two Studies Presented at the International Symposium on Nutritional Aspects of Osteoporosis Highlight the Positive Effects of Prunes The International Symposium on Nutritional Aspects of Osteoporosis (ISNAO) brings together the best scientific minds in bone health research and nutrition. Current research presented at the 2015 Ninth ISNAO has added to the increasing body of evidence… Read more »
The National Bone Health Alliance submitted a response to the BMJ’s recent article “Too Much Medicine: Overdiagnosis of bone fragility in the quest to prevent hip fractures.” While NBHA agrees with the article’s authors that osteoporosis and the resulting fractures are a terrible problem worldwide and responsible for high morbidity, mortality and loss of independence,… Read more »